Increasing productivity in biopharma R&D

The Gyrolab® platform uses groundbreaking microfluidic technology to automate immunoassays at nanoliter scale, so you reach your laboratory goals faster and deliver results that make a difference.

Accelerating time to insight

Using an affinity flow-through format, highly reproducible nanoliter microfluidics, and parallel processing, the Gyrolab platform transforms immunoassay workflows and shortens run times by automating assay steps, improving data quality.

Whether you’re looking for a complete system, a kit, or components, Gyrolab platforms miniaturize, integrate, and automate sample analysis at scale, maximizing your productivity and helping your lab make data-driven decisions – fast.

WEBINAR

Big pharma case study: alpha testing of a generic anti-AAV kit and comparison to in-house methods

Thursday January 30, 2025 – 08:00 PST / 11:00 EST / 16:00 GMT / 17:00 CET

Dr.EvaMariaThring round
Kira Hedström

SPEAKERS:
Eva-Maria Thüring
Postdoc, Bioanalytical Department at Bayer

Kira Hedtröm
Application Scientist at Gyros Protein Technologies

 

Gyrolab Technology Improving bioanalysis workflows

Proprietary Gyrolab technology simplifies assay workflows by eliminating incubations and shortening run times.


Reaching biologics development goals faster

Our highly experienced scientists understand the best approaches to optimize your processes, remove obstacles to your work, and help you reach your goals faster.

Subscribe to the immunoassay's newsletter
YouTube
Follow us on LI